-+ 0.00%
-+ 0.00%
-+ 0.00%

MOLECULIN BIOTECH INC - RECEIVES NASDAQ DEFICIENCY LETTER FOR BID PRICE - SEC FILING

Reuters·06/27/2025 21:04:31

Please log in to view news